BCIQ Profiles

Company Profile Report

Team identifies new target for MM CAR T therapy

In a paper published in Nature Medicine, researchers at Osaka University and colleagues identified activated integrin beta(7) as a new target for a chimeric antigen receptor (CAR) T cell therapy for multiple myeloma, demonstrating that a particular conformation of a cell surface antigen expressed on

Read the full 453 word article

How to gain access

Continue reading with a
two-week free trial.